Humana's Q4 Losses Widen on High Medical Costs; 2026 Earnings Outlook Cut

Humana reported a wider fourth-quarter loss of $1.01 billion, up from $862 million the previous year. The company attributed these escalating losses primarily to surging medical costs. Furthermore, Humana anticipates a significant decline in its 2026 earnings, mainly due to downgraded quality ratings for its Medicare plans. Despite these challenges, the company's revenue for the quarter rose to $32.52 billion, surpassing Wall Street expectations. These developments highlight ongoing financial pressures for Humana, particularly with rising costs and the impact of quality assessments on future performance.